TRX-818 sodium ( Foslinanib sodium )

Catalog No. M11046 CAS No. 1256037-62-3

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Group Booking Get Quotation Bulk Inquiry Add to Cart

Product Name

TRX-818 sodium
Note

Research use only, not for human use.
Brief Description

TRX-818 sodium (Foslinanib sodium ) is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities.
Description

TRX-818 sodium (Foslinanib sodium ) is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities, induces cancer cell apoptosis and inhibits cancer cell proliferation; also prevents tumor cell VM by blocking the formation of vasculogenic-like tubular structures through an as of yet undetermined mechanism of action.Liver Cancer Phase 2 Clinical
Synonyms

Foslinanib sodium
Pathway

Others
Target

Other Targets
Recptor

Other Targets
Research Area

Cancer
Indication

Liver Cancer

CAS Number

1256037-62-3
Formula Weight

393.22
Molecular Formula

C16H11FNNa2O5P
Purity

>98% (HPLC)
Solubility

——
SMILES

COC1=C(C2=C(C=C1)NC(=CC2=O)C3=CC(=CC=C3)F)OP(=O)([O-])[O-].[Na+].[Na+]
Chemical Name

sodium (2-(3-fluorophenyl)-6-methoxy-4-oxo-1,4-dihydroquinolin-5-yl)phosphonate